Format

Send to

Choose Destination
Neurochem Res. 2003 Jul;28(7):1041-7.

Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review.

Author information

1
Center for Dementia Research, Nathan Kline Institute/Department of Psychiatry, NYU School of Medicine, 140 Old Orangeburg Road, Orangeburg, New York 10962, USA. rao@nki.rfmh.org

Abstract

Neurofilament proteins synthesized in the cell body of neurons are assembled and transported into axons, where they influence axon radial growth, axonal transport, and nerve conduction velocities. In diseased states, neurofilaments accumulate in cell bodies and proximal axons of affected neurons, and these lesions are characteristic of many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), spinal muscular atrophy (SMA), Charcot-Marie-Tooth disease type 2 (CMT2), and hereditary sensory motor neuropathy. Although the molecular mechanisms that contribute to these accumulations are not yet identified, transgenic mouse models are beginning to provide insight into the role of neurofilament transport in disease-related dysfunction of neurons. This review addresses axonal transport in mouse models of ALS and the special significance of neurofilament transport in this disease.

PMID:
12737529
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center